Visit the institution website for COVID‑19 updates
To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields.
Candidates who do not meet these entry criteria but who can show relevant experience may also be considered.
Months of entry
This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process.
It addresses key aspects of preclinical drug evaluation through the study of:
- Drug discovery and development
- Safety pharmacology
- Mechanisms of drug-induced toxicities
- Regulatory affairs
- Bioanalytical sciences.
It will give you state-of-the-art training in preclinical toxicology, with an emphasis on the molecular in vitro and in vivo aspects of toxicology and safety pharmacology assessments.
As part of the programme you will undertake an original research project that will be the basis of your dissertation.
Delivered at the Institute of Cancer Therapeutics, an internationally renowned research institution, the programme gives you the skills you need for a career in the pharmaceutical industry or regulatory bodies, along with the foundations for PhD study.
Drug toxicology and safety pharmacology lies at the heart of the chemical and pharmaceutical industries, and demand for highly skilled practitioners in this field is extremely high.
Qualification, course duration and attendance options
- full time12 months
- Campus-based learningis available for this qualification
Course contact details
- Postgraduate Admissions